An RSS news feed below is not loading correctly. You can e-mail us at firstname.lastname@example.org with questions.
Read current official WHO and CDC news updates, listed below in the Newsfeeds section, descending from the most recent on top. See the notices from both organizations mapped globally immediately below.**
WHO Disease Outbreaks
Cholera – Togo...
Mon, 04 Jan 2021From 11 November to 28 December, 2020 a total of 67 suspected cholera cases presenting with diarrhea and vomiting, including two deaths a case fatality ratio (CFR: 3%) were reported from the municipalities “Golfe 1” and “Golfe 6” in Lomé, Togo. A total of four health areas (Katanga, Adakpamé, Gbétsogbé in Golfe 1, and Kangnikopé in Golfe 6) in the affected municipalities reported at least one case.
On 17 November, cholera was confirmed by culture in the laboratory of the National Institute of Hygiene (INH) in Lomé, Togo and WHO was informed. On 19 November, the Minister of Health, Public Hygiene and Universal Access to Care of Togo issued a press release declaring a cholera outbreak and on 24 November WHO was officially notified. From 11 November to 28 December 2020, a total of 17 out of 41 stool samples tested positive for Vibrio cholerae O1 serotype Ogawa by culture in the National Institute of Hygiene (INH) in Lomé, Togo.
Influenza A(H1N2) variant virus – Brazil ...
Mon, 04 Jan 2021On 15 December 2020, the Brazil Ministry of Health reported the second confirmed human infection with influenza A(H1N2) variant virus [A(H1N2)v] in Brazil in 2020.
Thu, 31 Dec 2020SARS-CoV-2, the virus that causes COVID-19, has had a major impact on human health globally; infecting a large number of people; causing severe disease and associated long-term health sequelae; resulting in death and excess mortality, especially among older and vulnerable populations; interrupting routine healthcare services; disruptions to travel, trade, education and many other societal functions; and more broadly having a negative impact on peoples physical and mental health. Since the start of the COVID-19 pandemic, WHO has received several reports of unusual public health events possibly due to variants of SARS-CoV-2. WHO routinely assesses if variants of SARS-CoV-2 result in changes in transmissibility, clinical presentation and severity, or if they impact on countermeasures, including diagnostics, therapeutics and vaccines. Previous reports of the D614G mutation and the recent reports of virus variants from the Kingdom of Denmark, the United Kingdom of Great Britain and Northern Ireland, and the Republic of South Africa have raised interest and concern in the impact of viral changes.
A variant of SARS-CoV-2 with a D614G substitution in the gene encoding the spike protein emerged in late January or early February 2020. Over a period of several months, the D614G mutation replaced the initial SARS-CoV-2 strain identified in China and by June 2020 became the dominant form of the virus circulating globally. Studies in human respiratory cells and in animal models demonstrated that compared to the initial virus strain, the strain with the D614G substitution has increased infectivity and transmission. The SARS-CoV-2 virus with the D614G substitution does not cause more severe illness or alter the effectiveness of existing laboratory diagnostics, therapeutics, vaccines, or public health preventive measures.
CDC Travel Notices:
COVID-19 Moderate - COVID-19 in Singapore...
Tue, 19 Jan 2021Travelers at increased risk for severe illness from COVID-19 should avoid all nonessential travel to Singapore.
COVID-19 Very High - COVID-19 in Seychelles...
Tue, 19 Jan 2021Travelers should avoid all travel to Seychelles.
COVID-19 Very High - COVID-19 in Saint Lucia ...
Tue, 19 Jan 2021Travelers should avoid all travel to Saint Lucia.
COVID-19 High - COVID-19 in Saint Vincent and the Grenadines...
Tue, 19 Jan 2021Travelers should avoid nonessential travel to Saint Vincent and the Grenadines.
COVID-19 Very High - COVID-19 in the Faroe Islands ...
Tue, 19 Jan 2021Travelers should avoid all travel to the Faroe Islands.
Click here to search for travel related diseases by country.
The Travel Clinical Assistant (TCA) is by the Georgia Department of Health.
CDC Morbidity and Mortality Weekly Report (MMWR):
EARLY RELEASE: SARS-CoV-2 Transmission Associated with High Schoo...
Tue, 26 Jan 2021This report describes SARS-CoV-2 transmission among attendees of two high school wrestling tournaments and their contacts.
EARLY RELEASE: COVID-19 Cases and Transmission in 17 K-12 Schools...
Tue, 26 Jan 2021This report describes reported student mask-wearing and COVID-19 rates among students and staff members in 17 rural Wisconsin schools.
Current Journal UpdatesSkip Current Journal Updates
Clinical Infectious Diseases Journal
This list includes items from the latest issue of the Clinical Infectious Diseases Journal.
Listen: New England Journal of Medicine
The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.
An International Look at Covid-19...
Wed, 20 Jan 2021Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Krista Nottage is a Bahamian surgeon and former New England Journal of Medicine editorial fellow. James O’Connell is an infectious disease physician in Ireland and New England Journal of Medicine editorial fellow. Gary Wong is a pulmonologist in Hong Kong and associate editor of the New England Journal of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. Audio Interview: An International Look at Covid-19. N Engl J Med 2021;384:e19.
NEJM Interview: Dr. Pardis Sabeti on the importance of testing du...
Wed, 20 Jan 2021Dr. Pardis Sabeti is an institute member of the Broad Institute of Harvard and MIT and a professor at Harvard University and the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Botti-Lodovico, E. Rosenberg, and P.C. Sabeti. Testing in a Pandemic — Improving Access, Coordination, and Prioritization. N Engl J Med 2021;384:197-199.
Covid-19 in South Africa and a New SARS-CoV-2 Variant...
Wed, 13 Jan 2021Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Salim Abdool Karim is a clinical infectious disease epidemiologist based in Durban, South Africa. His work, particularly with HIV, has earned him many international awards, including most recently the Canada Gairdner Global Health Award. He has led the South African Medical Research Council and is a member of the British Royal Society and the U.S. National Academy of Medicine. He currently heads the Ministerial Advisory Committee on Covid-19 for the Government of South Africa. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. N Engl J Med 2021;384:e14.
Emerging Infectious Diseases Journal:
This list contains articles published online ahead of print.
Dynamic Public Perceptions of the Coronavirus Disease Crisis, the...
Mon, 25 Jan 2021M. de Vries et al.
Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, Decembe...
Mon, 25 Jan 2021I. Claro et al.
Prevalence of SARS-CoV-2 Antibodies in First Responders and Publi...
Mon, 25 Jan 2021S. Sami et al.
Center for Infectious Disease Research and Policy:
News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).
Children, teens report mental distress amid pandemic remote learn...
Tue, 26 Jan 2021
COVID-19 Scan for Jan 26, 2021...
Tue, 26 Jan 2021COVID antibodies in front-line workersCumulative smoking and COVID-19
News Scan for Jan 26, 2021...
Tue, 26 Jan 2021Rift Valley fever in KenyaMore H5N8 avian flu in poultry
Johns Hopkins Medicine RSS Feed:
Johns Hopkins Medicine science and medical news.
Story Tips from Johns Hopkins Experts on COVID-19...
Tue, 26 Jan 2021Vaccines take time to work. After getting a COVID-19 vaccine, it takes a while for the immune system to fully respond and provide protection from the virus. For the Moderna and Pfizer COVID-19 vaccines, it takes up to two weeks after the second shot to become appropriately protected.
Johns Hopkins Medicine Hosts Briefing on COVID-19: One Year Later...
Mon, 25 Jan 2021A Woman's Journey will host a 90-minute virtual event, "COVID-19: One Year Later," during which Johns Hopkins Medicine experts will address important issues related to COVID-19 such as new and available treatments and vaccine safety and efficacy. Registrants will learn about the continued urgency of public health measures to mitigate the pandemic despite the introduction of vaccines, what distinguishes the leading vaccine contenders in their methodology, safety and effectiveness, and symptoms and insights surrounding lingering deficits in physical function, mental health and cognition among COVID-19 survivors.
Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine...
Tue, 19 Jan 2021During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our "COVID-19 Tip Sheet: Story Ideas from Johns Hopkins" every other Tuesday.
American Journal of Infection Control:
RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'
Gaps in Infection Prevention Practices for Catheter-associated U...
2021-01-21Device-associated infections, including catheter-associated urinary tract infections (CAUTI) and central line-associated bloodstream infections (CLABSI), are a leading cause of healthcare-associated infections (HAIs)1 and are associated with increased morbidity, mortality, and healthcare costs.2-4 Due to the seriousness of these infections, the U.S. Department of Health and Human Services set a national goal of reducing infections among hospitalized patients by 25% for CAUTI and 50% for CLABSI from 2015 to 2020.
EDUCATION, TRAINING, AND KNOWLEDGE OF INFECTION CONTROL AMONG EN...
2021-01-21Past research around endoscope reprocessing has primarily studied personnel's levels of adherence to institutional reprocessing protocols, demonstrating that compliance to protocol is typically low.1, 2 However, these studies do not explore how personnel's understanding of reprocessing guidelines and infection control factor into the issue.
First Reported Outbreak of the Emerging Pathogen Candida auris i...
2021-01-20Candida auris was first described in Japan in 2009 and has since been detected in over 40 countries. The yeast is concerning for multiple reasons, primarily: (1) challenges with accurate identification; (2) reported multi-drug resistance; (3) published mortality rates of 30 – 60%; and (4) persistence in the environment associated with human transmission. We report the emergence of a healthcare-associated cluster in the Greater Vancouver area in 2018 and describe the measures implemented to contain its transmission.